YourChoice Therapeutics
YC W19San Francisco, US · Founded 2018 · 3 employees · 8 known investors
Find your way into YourChoice Therapeutics
791 people in our graph share verified history with the YourChoice Therapeutics team — schools, employers, funds. One of them is your warm intro.
YourChoice Therapeutics develops YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials that works by blocking a receptor essential for sperm production. The company targets men seeking an alternative to condoms or vasectomy.
Founders & leadership· Y Combinator alumni (W19)
YourChoice Therapeutics was founded in 2018 by Akash Bakshi and Nadja Mannowetz.
Investors · 8
Funding
SEC filings, press & company announcements$15M disclosed across 1 round · 2022
- $15MSeries AJul 2022 · 2 sources
Future Ventures (lead), North South Ventures, Olive Tree Capital, RH Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does YourChoice Therapeutics do?
- YourChoice Therapeutics develops YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials that works by blocking a receptor essential for sperm production. The company targets men seeking an alternative to condoms or vasectomy.
- Who founded YourChoice Therapeutics?
- YourChoice Therapeutics was founded by Akash Bakshi, Nadja Mannowetz in 2018.
- Who are YourChoice Therapeutics's investors?
- YourChoice Therapeutics's investors include Blue Bear Ventures, Foreground Capital, Olive Tree Capital, Portfolia, Y Combinator, Future Ventures, North South Ventures, RH Capital.
- How much funding has YourChoice Therapeutics raised?
- YourChoice Therapeutics has disclosed $15M raised across 1 round.
- Where is YourChoice Therapeutics headquartered?
- YourChoice Therapeutics is headquartered in San Francisco, US.